Kiniksa Pharmaceuticals International, plc Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Kiniksa Pharmaceuticals International, plc stock issued during period, value, new issues for the quarter ending 2018-12-31 was $0.00.
- Kiniksa Pharmaceuticals International, plc stock issued during period, value, new issues for the quarter ending 2018-09-30 was $21.00K.
- Kiniksa Pharmaceuticals International, plc stock issued during period, value, new issues for fiscal 2018 was $155.54M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $155.54M 10-K · filed 2019-03-12 |
| 2018-09-30 | $21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 |